Pacific Biosciences of California Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Healthcare Portfolio Performance - Small Stocks Perk Up!
Article By: Rod Raynovich
Saturday, November 14, 2020 2:43 PM EST
Three weeks ago, we suggested that investors stay the course with healthcare and biotech because of potential volatility with the 2020 Election and COVID-19 cases spiking. We have seen a big shift toward energy, financial, and industrial stocks.
In this article: ABBV, ABT, MRK, NVAX, PACB, MRNA, NTLA, OCUL, BHVN, TWST, BNTX, CVAC Also: DNLI, IWM, XBI
Read
Biotech Stock Playbook In A Choppy Momentum Market
Article By: Rod Raynovich
Tuesday, September 29, 2020 4:57 AM EST
Biotech stocks peaked in mid-July but we have assumed a fourth quarter rally driven by clinical news in oncology and important scientific breakthroughs in diagnostic testing for coronavirus and COVID vaccine data.
In this article: ABT, AZN, BMY, GSK, JNJ, MRK, RHHBY, GNMK, NVAX, OSUR, QDEL, HOLX, PACB, ABBV, AXDX, EDIT, CRSP
Read
Pacific Biosciences Upgraded To Overweight From Neutral At Piper Jaffray
Article By: The Fly
Tuesday, October 15, 2019 7:33 AM EST
Piper Jaffray analyst William Quirk upgraded Pacific Biosciences of California to Overweight from Neutral with an unchanged price target of $8.
In this article: PACB Also: ILMN
Read
Merger Arbitrage Spread Performance - Feb. 24, 2019
Article By: Mal Spink
Sunday, February 24, 2019 2:18 PM EST
This is the analysis and performance review of the top 20 US based cash merger arbitrage spreads for the week 19th-22nd February. Included in this week's report are the winners, losers and overall performance of the portfolio.
In this article: NXTM, RHT NOW IBM, TRCO, NXST, PACB, MNA, SPY, HIFR
Read
Illumina To Acquire Pacific Biosciences For $8 Per Share
Article By: The Fly
Thursday, November 1, 2018 5:15 PM EST
The agreement has been approved by the board of directors of Illumina and Pacific Biosciences. The acquisition complements Illumina sequencing solutions with accurate long-read sequencing capabilities to answer a set of complex genomic questions.
In this article: ILMN, PACB
Read

Latest Tweets for $PACB

No tweets yet!